参考文献/References:
[1]Xu J,Lo S,Juergens CP,et al. Impact of targeted therapies for coronary microvascular dysfunction as assessed by the index of microcirculatory resistance[J]. J Cardiovasc Transl Res ,2021,14(2):327-337.
[2]Koek HL,Soedamah-Muthu SS,Kardaun JW,et al. Short- and long-term mortality after acute myocardial infarction:comparison of patients with and without diabetes mellitus[J]. Eur J Epidemiol ,2007,22(12):883-888.
[3]de Waha S,Patel MR,Granger CB,et al. Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction:an individual patient data pooled analysis from seven randomized trials[J]. Eur Heart J ,2017,38(47):3502-3510.
[4]Sheng X,Ding S,Ge H,et al. Intracoronary infusion of alprostadil and nitroglycerin with targeted perfusion microcatheter in STEMI patients with coronary slow flow phenomenon[J]. Int J Cardiol ,2018,265:6-11.
[5]Niccoli G,Burzotta F,Galiuto L,et al. Myocardial no-reflow in humans[J]. J Am Coll Cardiol ,2009,54(4):281-292.
[6]Sheng X,Qiao Z,Ge H,et al. Novel application of quantitative flow ratio for predicting microvascular dysfunction after ST-segment-elevation myocardial infarction[J]. Catheter Cardiovasc Interv,2020,95(suppl 1):624-632.
[7]de Maria GL,Alkhalil M,Borlotti A,et al. Index of microcirculatory resistance-guided therapy with pressure-controlled intermittent coronary sinus occlusion improves coronary microvascular function and reduces infarct size in patients with ST-elevation myocardial infarction:the oxford acute myocardial infarction - pressure-controlled intermittent coronary sinus occlusion study (OxAMI-PICSO study)[J]. EuroIntervention ,2018,14(3):e352-e359.
[8]de Maria GL,Scarsini R,Shanmuganathan M,et al. Angiography-derived index of microcirculatory resistance as a novel,pressure-wire-free tool to assess coronary microcirculation in ST elevation myocardial infarction[J]. Int J Cardiovasc Imaging ,2020,36(8):1395-1406.
[9]Spitaleri G,Tebaldi M,Biscaglia S,et al. Quantitative flow ratio identifies nonculprit coronary lesions requiring revascularization in patients with ST-segment-elevation myocardial infarction and multivessel disease[J]. Circ Cardiovasc Interv ,2018,11(2):e006023.
[10]Tu S,Barbato E,K?szegi Z,et al. Fractional flow reserve calculation from 3-dimensional quantitative coronary angiography and TIMI frame count:a fast computer model to quantify the functional significance of moderately obstructed coronary arteries[J]. JACC Cardiovasc Interv ,2014,7(7):768-777.
[11]Tu S,Westra J,Yang J,et al. Diagnostic accuracy of fast computational approaches to derivefractional flow reserve fromdiagnostic coronary angiography:the international multicenter FAVOR pilot study[J]. JACC Cardiovasc Interv ,2016,9(19):2024-2035.
[12]Mejía-Rentería H,Lee JM,Lauri F,et al. Influence of microcirculatory dysfunction on angiography-based functional assessment of coronary stenoses[J]. JACC Cardiovasc Interv ,2018,11(8):741-753.
[13]Maznyczka AM,McCartney PJ,Oldroyd KG,et al. Effects of intracoronary alteplase on microvascular function in acute myocardial infarction[J]. J Am Heart Assoc ,2020,9(3):e014066.
[14]Galaup A,Gomez E,Souktani R,et al. Protection against myocardial infarction and no-reflow through preservation of vascular integrity by angiopoietin-like 4[J]. Circulation ,2012,125(1):140-149.
[15]Sun Z,Zeng J,Huang H. Intracoronary injection of tirofiban prevents microcirculation dysfunction during delayed percutaneous coronary intervention in patients with acute myocardial infarction[J]. Int J Cardiol ,2016,208:137-140.
[16]Armstrong D,Summers C,Ewart L,et al. Characterization of the adenosine pharmacology of ticagrelor reveals therapeutically relevant inhibition of equilibrative nucleoside transporter 1[J]. J Cardiovasc Pharmacol Ther ,2014,19(2):209-219.
[17]Zhang Y,Wernly B,Cao X,et al. Adenosine and adenosine receptor-mediated action in coronary microcirculation[J]. Basic Res Cardiol ,2021,116(1):22.
[18]Wittfeldt A,Emanuelsson H,Brandrup-Wognsen G,et al. Ticagrelor enhances adenosine-induced coronary vasodilatory responses in humans[J]. J Am Coll Cardiol ,2013,61(7):723-727.
[19]Cattaneo M,Schulz R,Nylander S. Adenosine-mediated effects of ticagrelor:evidence and potential clinical relevance[J]. J Am Coll Cardiol ,2014,63(23):2503-2509.
[20]Park SD,Lee MJ,Baek YS,et al. Randomised trial to compare a protective effect of clopidogrel versus ticagrelor on coronary microvascular injury in ST-segment elevation myocardial infarction (CV-TIME trial)[J]. EuroIntervention ,2016,12(8):e964-e971.
[21]Patti G,Bárczi G,Orlic D,et al. Outcome comparison of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction:results from the ARMYDA-6 MI (antiplatelet therapy for reduction of myocardial damage during angioplasty-myocardial infarction) randomized study[J]. J Am Coll Cardiol ,2011,58(15):1592-1599.
[22]Gurbel PA,Bliden KP,Butler K,et al. Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease:the ONSET/OFFSET study[J]. Circulation ,2009,120(25):2577-2585.
[23]Park K,Cho YR,Park JS,et al. Comparison of the effects of ticagrelor and clopidogrel on microvascular dysfunction in patients with acute coronary syndrome using invasive physiologic indices[J]. Circ Cardiovasc Interv ,2019,12(10):e008105.
[24]van Leeuwen MAH,van der Hoeven NW,Janssens GN,et al. Evaluation of microvascular injury in revascularized patients with ST-segment-elevation myocardial infarction treated with ticagrelor versus prasugrel[J]. Circulation ,2019,139(5):636-646.
[25]Wu KC. CMR of microvascular obstruction and hemorrhage in myocardial infarction[J]. J Cardiovasc Magn Reson ,2012,14(1):68.
[26]Sutton MG,Sharpe N. Left ventricular remodeling after myocardial infarction:pathophysiology and therapy[J]. Circulation ,2000,101(25):2981-2988.
[27]Nijveldt R,Beek AM,Hirsch A,et al. Functional recovery after acute myocardial infarction:comparison between angiography,electrocardiography,and cardiovascular magnetic resonance measures of microvascular injury[J]. J Am Coll Cardiol ,2008,52(3):181-189.
[28]?rn S,Manhenke C,Greve OJ,et al. Microvascular obstruction is a major determinant of infarct healing and subsequent left ventricular remodelling following primary percutaneous coronary intervention[J]. Eur Heart J ,2009,30(16):1978-1985.
[29]Baks T,van Geuns RJ,Biagini E,et al. Effects of primary angioplasty for acute myocardial infarction on early and late infarct size and left ventricular wall characteristics[J]. J Am Coll Cardiol ,2006,47(1):40-44.
[30]Carrick D,Haig C,Carberry J,et al. Microvascular resistance of the culprit coronary artery in acute ST-elevation myocardial infarction[J]. JCI Insight ,2016,1(6):e85768.
[31]Fearon WF,Low AF,Yong AS,et al. Prognostic value of the index of microcirculatory resistance measured after primary percutaneous coronary intervention[J]. Circulation ,2013,127(24):2436-2441.
[32]de Maria GL ,Alkhalil M,Wolfrum M,et al. Index of microcirculatory resistance as a tool to characterize microvascular obstruction and to predict infarct size regression in patients with STEMI undergoing primary PCI[J]. JACC Cardiovasc Imaging ,2019,12(5):837-848.
[33]Carrick D,Haig C,Ahmed N,et al. Comparative prognostic utility of indexes of microvascular function alone or in combination in patients with an acute ST-segment-elevation myocardial infarction[J]. Circulation ,2016,134(23):1833-1847.
相似文献/References:
[1]刘丹丹 王海珠 任凤波.ST段抬高型心肌梗死PCI术后血浆微囊泡浓度对再次血运重建的风险预测分析[J].心血管病学进展,2019,(7):1056.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.023]
LIU Dandan,WANG Haizhu,REN Fengbo.Predictive analysis of plasma microvesicles concentration in patients with ST-segment elevation myocardial infarction after target lesion revascularization[J].Advances in Cardiovascular Diseases,2019,(6):1056.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.023]
[2]金荣杰 徐勇 邓珏琳 沈明志.应用心脏磁共振评估前列地尔对ST段抬高型心肌梗死患者心肌灌注的影响[J].心血管病学进展,2020,(10):1096.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.023]
JIN RongjieXU YongDENG JuelinSHEN Mingzhi.Effect of Alprostadil on Myocardial Perfusion of Patients with ST Segment Elevation Myocardial Infarction Directly Receiving Percutaneous Coronary Intervention Assessed with Cardiac Magnetic Resonance[J].Advances in Cardiovascular Diseases,2020,(6):1096.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.023]
[3]贺彩红 荣晶晶 潘宏伟.定量血流分数在急性心肌梗死中的应用进展[J].心血管病学进展,2021,(4):347.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.014]
HE Caihong,RONG Jingjing,PAN Hongwei.Progress in the Application of Quantitative Flow Ratio in Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2021,(6):347.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.014]
[4]陈佳仑 李树仁.不同策略血栓抽吸对于急性ST段抬高心肌梗死患者的研究进展[J].心血管病学进展,2021,(7):593.[doi:10.16806/j.cnki.issn.1004-3934.2021.07.005]
CHEN Jialun,LI Shuren.Different Strategies of Thrombus Aspiration in Patients with Acute ST Elevation Myocardial Infarction[J].Advances in Cardiovascular Diseases,2021,(6):593.[doi:10.16806/j.cnki.issn.1004-3934.2021.07.005]
[5]周星儿 赵施皓 郭宇婷 金荣杰 王继航 王建 郭毅 田进文 沈明志.冠状动脉溶栓在ST段抬高型心肌梗死中的研究进展[J].心血管病学进展,2022,(3):229.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
ZHOU Xinger,ZHAO Shihao,GUO Yuting,et al.Coronary Thrombolysis in ST-Segment Elevation Myocardial Infarction[J].Advances in Cardiovascular Diseases,2022,(6):229.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
[6]梁晨笛 秦纲.经皮冠状动脉介入诊疗中穿刺路径研究进展[J].心血管病学进展,2022,(3):232.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
LIANG Chendi,QIN Gang.Puncture Routes in Percutaneous Coronary Intervention[J].Advances in Cardiovascular Diseases,2022,(6):232.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
[7]马兴鸿 汪蕾 方纬.核素心肌显像在冠状动脉慢性完全闭塞临床诊疗中的应用价值[J].心血管病学进展,2022,(4):313.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.007]
MA Xinghong,WANG Lei,FANG Wei.Application Value of Radionuclide Myocardial Imaging In the Clinical Diagnosis And Treatment of Coronary Chronic Total Occlusion[J].Advances in Cardiovascular Diseases,2022,(6):313.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.007]
[8]张爽 吴娜琼.腔内影像学在冠状动脉支架内再狭窄诊治应用中的研究进展[J].心血管病学进展,2022,(5):389.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.002]
ZHANG Shuang,WU Na qiong.Application of Intravascular Imaging in Diagnosis and Treatment of Coronary In-Stent Restenosis[J].Advances in Cardiovascular Diseases,2022,(6):389.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.002]
[9]管翔 王宇 张成糕 周健 张艺 李庆国.经皮心室辅助装置在复杂高危冠状动脉介入治疗中的应用进展[J].心血管病学进展,2022,(5):394.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.003]
GUAN Xiang,WANG Yu,ZHANG Chenggao,et al.Application Progress of Percutaneous Ventricular Assist Device in Complex High-Risk Coronary Intervention[J].Advances in Cardiovascular Diseases,2022,(6):394.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.003]
[10]刘文 魏芳晶.药物涂层球囊在真性分叉病变中的研究进展[J].心血管病学进展,2022,(6):511.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.008]
LIU WenWEI Fangjing.Study of Drug-Coated?Balloon in?rue Coronary Bifurcation Lesions[J].Advances in Cardiovascular Diseases,2022,(6):511.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.008]
[11]韩培天 魏晓岩 杜彬彬 张津宁 王文州 郭艳娇 张克成 李春彦 李文慧.心肌缺血时间对STEMI患者急诊PCI术后早期左室舒张功能的影响及相关因素分析[J].心血管病学进展,2020,(6):660.[doi:10.16806/j.cnki.issn.1004-3934.2020.06.024]
HAN Pei-tian,WEI Xiaoyan,DU Binbin,et al.Effect of Myocardial Ischemia Duration on Early Left Ventricular Diastolic Function in STEMI Patients After Emergency PCI and Analysis of Related Factors[J].Advances in Cardiovascular Diseases,2020,(6):660.[doi:10.16806/j.cnki.issn.1004-3934.2020.06.024]